Register for the Webinar to Learn More.
Too often, manufacturing is treated as an afterthought in drug development—a downstream function to be addressed once R&D milestones are met. But in today’s complex and competitive environment, overlooking manufacturing early in the process can lead to costly delays, supply chain vulnerabilities, and missed opportunities to accelerate therapies to patients.
This webinar explores why integrating manufacturing into every stage of the development journey is critical. Experts will share how end-to-end manufacturing strategies—backed by optimized processes, cross-functional planning, and the right technology—can reduce risk, increase efficiency, and help organizations achieve faster speed to market. Attendees will walk away with a clear understanding of how a holistic approach to manufacturing can unlock long-term value across the entire drug development value chain.
Key Takeaways
- How to embed CMC and manufacturing strategy at every stage of the product lifecycle.
- Best practices for engaging CDMOs early and building collaborative, repeatable processes.
- Common operational challenges (e.g., tech transfer, capacity scaling, supply chain hurdles) and how to overcome them.
- Why a strategic, end-to-end view of operations is critical for reducing risk and maximizing long-term value.
Offered Free by: IPM
See All Resources from: IPM
